BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 29103791)

  • 1. Reversal of Glaucoma Hemifield Test Results and Visual Field Features in Glaucoma.
    Wang M; Pasquale LR; Shen LQ; Boland MV; Wellik SR; De Moraes CG; Myers JS; Wang H; Baniasadi N; Li D; Silva RNE; Bex PJ; Elze T
    Ophthalmology; 2018 Mar; 125(3):352-360. PubMed ID: 29103791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misleading statistical calculations in far-advanced glaucomatous visual field loss.
    Blumenthal EZ; Sapir-Pichhadze R
    Ophthalmology; 2003 Jan; 110(1):196-200. PubMed ID: 12511366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and Rates of Visual Field Loss across Different Disease Stages in Primary Open-Angle Glaucoma.
    Yousefi S; Mahmoudi Nezhad GS; Pourahmad S; Vermeer KA; Lemij HG
    Ophthalmol Glaucoma; 2018; 1(1):52-60. PubMed ID: 32672633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Global Test-Retest Variability of Visual Fields in Glaucoma.
    Choi EY; Li D; Fan Y; Pasquale LR; Shen LQ; Boland MV; Ramulu P; Yousefi S; De Moraes CG; Wellik SR; Myers JS; Bex PJ; Elze T; Wang M
    Ophthalmol Glaucoma; 2021; 4(4):390-399. PubMed ID: 33310194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing glaucoma progression on 24-2 and 10-2 visual field examinations.
    Rao HL; Begum VU; Khadka D; Mandal AK; Senthil S; Garudadri CS
    PLoS One; 2015; 10(5):e0127233. PubMed ID: 25978316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
    Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence Classification of Central Visual Field Patterns in Glaucoma.
    Wang M; Shen LQ; Pasquale LR; Boland MV; Wellik SR; De Moraes CG; Myers JS; Nguyen TD; Ritch R; Ramulu P; Wang H; Tichelaar J; Li D; Bex PJ; Elze T
    Ophthalmology; 2020 Jun; 127(6):731-738. PubMed ID: 32081491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Long-Term Visual Field Fluctuation in Glaucoma Patients.
    Rabiolo A; Morales E; Kim JH; Afifi AA; Yu F; Nouri-Mahdavi K; Caprioli J
    Ophthalmology; 2020 Jun; 127(6):739-747. PubMed ID: 31952885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the Amsler Grid Test in Evaluating Glaucomatous Central Visual Field Defects.
    Su D; Greenberg A; Simonson JL; Teng CC; Liebmann JM; Ritch R; Park SC
    Ophthalmology; 2016 Apr; 123(4):737-43. PubMed ID: 26783097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the Reliability of Glaucomatous Visual Field for the Accurate Assessment of Progression Using the Gaze-Tracking and Reliability Indices.
    Asaoka R; Fujino Y; Aoki S; Matsuura M; Murata H
    Ophthalmol Glaucoma; 2019; 2(2):111-119. PubMed ID: 32672604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Transitioning from SITA Standard to SITA Faster on Visual Field Performance.
    Pham AT; Ramulu PY; Boland MV; Yohannan J
    Ophthalmology; 2021 Oct; 128(10):1417-1425. PubMed ID: 33798655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the visual field index in glaucoma patients with moderately advanced visual field loss.
    Lee JM; Cirineo N; Ramanathan M; Nouri-Mahdavi K; Morales E; Coleman AL; Caprioli J
    Am J Ophthalmol; 2014 Jan; 157(1):39-43. PubMed ID: 24200229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography.
    Zhang X; Loewen N; Tan O; Greenfield DS; Schuman JS; Varma R; Huang D;
    Am J Ophthalmol; 2016 Mar; 163():29-37. PubMed ID: 26627918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parafoveal scotoma progression in glaucoma: humphrey 10-2 versus 24-2 visual field analysis.
    Park SC; Kung Y; Su D; Simonson JL; Furlanetto RL; Liebmann JM; Ritch R
    Ophthalmology; 2013 Aug; 120(8):1546-50. PubMed ID: 23697959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying "Lasso" Regression to Predict Future Visual Field Progression in Glaucoma Patients.
    Fujino Y; Murata H; Mayama C; Asaoka R
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2334-9. PubMed ID: 25698708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Glaucoma Progression Using Machine Learning Trained on Longitudinal Visual Field and Clinical Data.
    Dixit A; Yohannan J; Boland MV
    Ophthalmology; 2021 Jul; 128(7):1016-1026. PubMed ID: 33359887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Correlates of Computationally Derived Visual Field Defect Archetypes in Patients from a Glaucoma Clinic.
    Cai S; Elze T; Bex PJ; Wiggs JL; Pasquale LR; Shen LQ
    Curr Eye Res; 2017 Apr; 42(4):568-574. PubMed ID: 27494512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of Visual Field Loss in Primary Angle-Closure Glaucoma Across Different Severity Levels.
    Atalay E; Nongpiur ME; Yap SC; Wong TT; Goh D; Husain R; Perera SA; Aung T
    Ophthalmology; 2016 Sep; 123(9):1957-64. PubMed ID: 27423311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating progression of visual field loss in glaucoma.
    Katz J; Gilbert D; Quigley HA; Sommer A
    Ophthalmology; 1997 Jun; 104(6):1017-25. PubMed ID: 9186444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities for Improving Glaucoma Clinical Trials via Deep Learning-Based Identification of Patients with Low Visual Field Variability.
    Wang R; Bradley C; Herbert P; Hou K; Hager GD; Breininger K; Unberath M; Ramulu P; Yohannan J
    Ophthalmol Glaucoma; 2024; 7(3):222-231. PubMed ID: 38296108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.